These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32926310)

  • 1. Temporal changes of incomplete stent apposition during early phase after everolimus-eluting stent implantation: serial optical coherence tomography analyses at 2-week and 4-month.
    Wakabayashi H; Ando H; Nakano Y; Takashima H; Waseda K; Shimoda M; Ohashi H; Suzuki A; Sakurai S; Amano T
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):411-417. PubMed ID: 32926310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study.
    Ishida K; Otsuki S; Giacchi G; Ortega-Paz L; Shiratori Y; Freixa X; Martín-Yuste V; Masotti M; Sabaté M; Brugaletta S
    Cardiovasc Revasc Med; 2017; 18(1):47-52. PubMed ID: 27634493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cut-off value of mal-apposition volume and depth for resolution at early phase of acute incomplete stent apposition after CoCr-EES implantation.
    Uchimura Y; Itoh T; Oda H; Taguchi Y; Sasaki W; Kaneko K; Sakamoto T; Goto I; Sakuma M; Ishida M; Kikuchi T; Terashita D; Otake H; Morino Y; Shinke T
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1979-1987. PubMed ID: 31256285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
    Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.
    Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P
    Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.
    Shimamura K; Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Yoshiyama M; Sonoda S; Igarashi K; Miyazawa A; Uzui H; Sakanoue Y; Shinke T; Morino Y; Tanabe K; Kadota K; Kimura T
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):23-8. PubMed ID: 25342855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cut-off value of strut-vessel distance for the resolution of acute incomplete stent apposition in the early phase using serial optical coherence tomography after cobalt-chromium everolimus-eluting stent implantation.
    Oda H; Itoh T; Sasaki W; Uchimura Y; Taguchi Y; Kaneko K; Sakamoto T; Goto I; Sakuma M; Ishida M; Kikuchi T; Terashita D; Otake H; Morino Y; Shinke T
    J Cardiol; 2020 Jun; 75(6):641-647. PubMed ID: 31924410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
    Sotomi Y; Onuma Y; Dijkstra J; Miyazaki Y; Kozuma K; Tanabe K; Popma JJ; de Winter RJ; Serruys PW; Kimura T
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):59-66. PubMed ID: 28158421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.
    Jaguszewski M; Aloysius R; Wang W; Bezerra HG; Hill J; De Winter RJ; Karjalainen PP; Verheye S; Wijns W; Lüscher TF; Joner M; Costa M; Landmesser U
    JACC Cardiovasc Interv; 2017 Mar; 10(5):489-499. PubMed ID: 28279316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Year Optical Coherence Tomography in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents.
    Gomez-Lara J; Brugaletta S; Jacobi F; Ortega-Paz L; Ñato M; Roura G; Romaguera R; Ferreiro JL; Teruel L; Gracida M; Martin-Yuste V; Freixa X; Masotti M; Gomez-Hospital JA; Sabate M; Cequier A
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27702766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early vascular responses to everolimus-eluting cobalt-chromium stent in the culprit lesions of st-elevation myocardial infarction: results from a multicenter prospective optical coherence tomography study (MECHANISM-AMI 2-week follow-up study).
    Morino Y; Terashita D; Otake H; Kikuchi T; Fusazaki T; Kuriyama N; Suzuki T; Ito Y; Hibi K; Tanaka H; Ishihara S; Kataoka T; Morita T; Otsuka Y; Hayashi T; Tanabe K; Shinke T
    Cardiovasc Interv Ther; 2019 Jan; 34(1):14-24. PubMed ID: 29318464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serial optical coherence tomography imaging following aggressive stent expansion technique: insight from the MECHANISM study.
    Sasaki W; Ishida M; Itoh T; Uchimura Y; Oda H; Taguchi Y; Kaneko K; Sakamoto T; Goto I; Sakuma M; Terashita D; Otake H; Shinke T; Morino Y
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):419-428. PubMed ID: 33034867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
    Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography findings after chronic total occlusion interventions: Insights from the "AngiographiC evaluation of the everolimus-eluting stent in chronic Total occlusions" (ACE-CTO) study (NCT01012869).
    Sherbet DP; Christopoulos G; Karatasakis A; Danek BA; Kotsia A; Navara R; Michael TT; Roesle M; Rangan BV; Haagen D; Garcia S; Maniu C; Pershad A; Abdullah SM; Hastings JL; Kumbhani DJ; Luna M; Addo T; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2016; 17(7):444-449. PubMed ID: 27133499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study.
    Otsuki S; Brugaletta S; Sabaté M; Shiratori Y; Gomez-Monterrosas O; Scalone G; Romero-Villafañe S; Hernández-Enríquez M; Freixa X; Martín-Yuste V; Masotti M
    Cardiovasc Revasc Med; 2016 Jun; 17(4):241-7. PubMed ID: 27158001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.
    Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):515-522. PubMed ID: 29159531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term in-stent vascular response between abluminal groove-filled biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent: 3-year OCT follow-up from the TARGET I trial.
    Xu B; Zhang YJ; Sun ZW; Qiao SB; Chen SL; Zhang RY; Pan DR; Pang S; Zhang Q; Xu L; Yang YJ; Leon MB; Gao RL
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1489-96. PubMed ID: 26208685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late-phase vascular response after everolimus-eluting stent implantation assessed by optical coherence tomography.
    Khalifa AKM; Ino Y; Kubo T; Tanimoto T; Shimamura K; Shiono Y; Takahata M; Terada K; Higashioka D; Wada T; Taruya A; Emori H; Katayama Y; Kashiwagi M; Kuroi A; Matsuo Y; Fujita S; Tanaka A; Hozumi T; Akasaka T
    Int J Cardiovasc Imaging; 2020 Sep; 36(9):1627-1635. PubMed ID: 32385540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.
    de la Torre Hernández JM; Tejedor P; Camarero TG; Duran JM; Lee DH; Monedero J; Laso FS; Calderón MA; Veiga G; Zueco J
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):E67-73. PubMed ID: 26526783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the vessel healing process after everolimus-eluting stent and bare metal stent implantations in patients with ST-elevation myocardial infarction.
    Yano H; Horinaka S; Watahik M; Watanabe T; Ishimitsu T
    Heart Vessels; 2019 Apr; 34(4):572-582. PubMed ID: 30392104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.